References

  1. Ries LAG, Smith MA, Gurney JG, et al, eds. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995 , National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD: National Cancer Institute, 1999.
  2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009;59(4):225–249. [PMID: 19474385]
  3. Bleyer A, O’Leary M, Barr R, Ries LAG (eds). Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000 . National Cancer Institute, NIH Pub. No. 06-5767. Bethesda, MD 2006.
  4. Crist WM, Anderson JR, Meza JL, et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 2001;19(12):3091. [PMID: 11408506]
  5. Pappo AS, Shapiro DN, Crist WM, et al. Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 1995;13(8):2123. [PMID: 7636557]
  6. Qualman SJ, Bowen J, Parham DM, et al. Protocol for the examination of specimens from patients (children and young adults) with rhabdomyosarcoma. Arch Pathol Lab Med 2003;127(10):1290. [PMID: 14521467]
  7. Maris JM, Weiss MJ, Mosse Y, et al. Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12–13. Cancer Res 2002;62(22):6651. [PMID: 12438263]
  8. Park JR, Eggert A, Caron H. Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin North Am 2010;24(1):65–86. [PMID: 20113896]
  9. Mosse YP, Laudenslager M, Longo L, et al. Identification of ALK as a major ...